Indication

Alpha-Thalassemia

1 clinical trial

1 product

Clinical trial

A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Mitapivat in Subjects With Transfusion-Dependent Alpha- or Beta-Thalassemia (ENERGIZE-T)

Status: Active (not recruiting), Estimated PCD: 2024-04-01

Product